NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Stock Information | RedChip

NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Listen to this Section


$0.53
+0.0428 ( +8.70% ) 702.8K

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -180,000.00 | $ -96,282.00

Date Type Amount Purchased Purchaser
2024-05-30 Sale -30000.00 Zheng Yongxiang
2024-05-30 Sale -30000.00 Zheng Yenyou
2024-05-30 Sale -30000.00 WU MIJIA
2024-05-30 Sale -30000.00 Sit Swan
2024-05-30 Sale -30000.00 Freiman Paul E.
2024-05-30 Sale -30000.00 Garlikov Julie

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 95 Aug 13, 2024
8-k 8K-related 23 Jul 29, 2024
8-k 8K-related 16 Jul 11, 2024
8-k 8K-related 17 Jun 14, 2024
8-k 8K-related 16 Jun 07, 2024
8-k/a 8K-related 15 May 31, 2024
8-k 8K-related 15 May 31, 2024
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.